<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE BALANCE
SHEETS AND STATEMENTS OF OPERATIONS FOUNDED ON PAGES 1-3 OF THE COMPANY'S FORM
10-QSB, FOR THE YEAR-TO-DATE AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO
SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0001016151
<NAME> AMPLIDYNE, INC.
<MULTIPLIER> 1
<CURRENCY> USD
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> DEC-31-1999
<PERIOD-START> JAN-01-2000
<PERIOD-END> SEP-30-2000
<EXCHANGE-RATE> 1
<CASH> 2,361,752
<SECURITIES> 0
<RECEIVABLES> 735,276
<ALLOWANCES> 282,310
<INVENTORY> 715,844
<CURRENT-ASSETS> 3,579,144
<PP&E> 803,375
<DEPRECIATION> 562,275
<TOTAL-ASSETS> 3,855,869
<CURRENT-LIABILITIES> 414,997
<BONDS> 0
0
0
<COMMON> 745
<OTHER-SE> 3,431,866
<TOTAL-LIABILITY-AND-EQUITY> 3,855,869
<SALES> 1,902,204
<TOTAL-REVENUES> 1,972,091
<CGS> 1,734,631
<TOTAL-COSTS> 2,115,269
<OTHER-EXPENSES> 1,507,292
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> (550)
<INCOME-PRETAX> (1,651,020)
<INCOME-TAX> 0
<INCOME-CONTINUING> (1,651,020)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (1,651,020)
<EPS-BASIC> (.23)
<EPS-DILUTED> (.23)
</TABLE>